Apexian Pharmaceuticals grabs Series A

Apexian Pharmaceuticals, an Indiana-based clinical stage biotechnology company, has raised an undisclosed amount of Series A funding. Apexian's investors included Elevate Ventures.

29 November 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail